Tocilizumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Tocilizumab and local guidelines before prescribing.

IL-6 receptor antagonist

Mechanism

Interleukin-6 receptor antagonist.

Uses

Rheumatoid arthritis, giant cell arteritis, COVID-19 (selected), cytokine release syndrome.

Dosing

Side effects

Infections, raised LFT and lipids, neutropenia, gastrointestinal perforation.

Interactions

Live vaccines contraindicated; CYP-substrate drug levels may fall.

Contraindications and cautions

Active infection, neutropenia

Monitoring

TB screen, FBC, LFT, lipids

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Caution in liver disease

Overdose and reversal

Supportive

Special advice

Screen for TB; monitor FBC and LFT; may blunt CRP and fever in infection.

More from the textbook: uses, cautions and other points
Where it is discussed in the book